Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
about
A national survey on the patterns of treatment of inflammatory bowel disease in CanadaSystematic review: has disease outcome in Crohn's disease changed during the last four decades?Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.Dynamic access of the glucocorticoid receptor to response elements in chromatin.Framework for assessing quality of care for inflammatory bowel disease in Sweden.Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.A population-based study of health-care resource use among infliximab users.Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?The association between corticosteroid use and development of fractures among IBD patients in a population-based database.Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease.Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.Early childhood measles vaccinations are not associated with paediatric IBD: a population-based analysis.Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.Treatment inferred disease severity in Crohn's disease: Evidence for a European gradient of disease course
P2860
Q24806918-627AC0D4-5F3E-45FD-9097-5E078942F301Q30839748-1A4AA60A-46F7-4E63-AC82-0A3CE9D9E9FFQ33268021-4F39A944-5E52-4A71-B428-1BEAADAB98D7Q34859890-99047864-DD12-440E-B647-B0132E46D731Q35813211-456E2E00-5224-486A-8CC2-19950B3794ECQ37113241-7FDF4C23-34DF-4492-B111-569A65ABDC30Q43107861-A7FE6CF1-9A5F-468B-B848-71BC1EB43CDEQ44039901-0165B437-2E69-49B1-AE4C-BAC9699B42FFQ44113788-B3FFDFA5-D820-4CCD-83AA-E0A1DFBBA2A0Q45399928-16EC3DDA-300A-4FAC-9B46-C48D416F7442Q45832729-C45CF401-EC98-444B-9798-B8AFCE91C2ACQ47249731-092539F4-6495-4FEC-B70B-52C528B05B20Q50583061-C152F0C6-D040-47AA-A6A6-074122EDD0C3Q51939595-6630E8E1-A024-4C3C-A9B6-1EA725A4EC19Q57265432-BEB74ACB-DFF9-420E-94D1-8D041833969B
P2860
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
@en
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
@nl
type
label
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
@en
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
@nl
prefLabel
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
@en
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
@nl
P2093
P2860
P1476
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
@en
P2093
Bernstein CN
Blanchard JF
Peterson S
P2860
P304
P356
10.1111/J.1572-0241.2001.05255.X
P407
P577
2001-12-01T00:00:00Z